Full-Time

Clinical Sales Specialist

Ibd

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$56.54 - $77.74/hr

+ Short-term Incentives

Senior

Cincinnati, OH, USA

Candidates should reside within or close proximity to assigned geography (Ohio).

Category
Field Sales
Sales & Account Management
Requirements
  • Bachelors' degree – BA/BS
  • 5 years direct selling experience to healthcare professionals in the pharmaceutical, biotech, device or healthcare industry and/or relevant clinical or industry experience.
  • Ability to discuss therapeutic strategies to inform and influence decision makers
  • Ability to successfully develop and apply clinical and business expertise, and effective selling skills
  • Strong verbal, influencing, presentation and written communication skills
  • Reside within or close proximity to assigned geography
Responsibilities
  • Research prospective Health Care Professionals (HCPs) to identify the right customer stakeholders to present complex clinical and business information on products and services including Gastroenterologists HCPs and professional or patient groups.
  • Use insight and consultative selling techniques to teach HCPs about their industry and offer unique perspectives on their business, which link back to Takeda's solutions.
  • Engage in clinical discussions with HCPs to discuss patients' needs, execute brand strategies and maximize sales growth within a specific geography. Coach customer stakeholders and build consensus for Takeda's solutions within their organization.
  • Collaborate with partners on routing and resource utilization to maximize overall footprint performance.
  • Independently and collaboratively strategizing for solving deal-level challenges.
  • Attend all company-sponsored sales and medical meetings as directed by company management.
  • Actively pursue learning and professional development on efficient sales, communication and product knowledge training.
  • Perform company business in accordance with all regulations and policies and procedures. Demonstrate high ethical and professional standards at all times.
  • Strategically manage allocated resources provided including financial/budgets, managed markets, medical affairs, home office, etc.
Desired Qualifications
  • Execution of marketing strategies at the local level
  • Demonstrated business and strategic planning skills to identify unique selling opportunities and adaptability to changing market conditions
  • Demonstrated understanding of managed care landscape and how it influences/impacts business
  • Strong collaboration skills and success working in teams
  • Experience with injectable/infused IBD (Inflammatory Bowel Disorder) products
  • Experience with managing and communicating complex reimbursement issues
  • Biological product launch experience
  • Experience in calling on Gastroenterologists

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, aiming for up to 15 product launches by FY2024. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between environmental health and human health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized and environmental risks are managed.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...